U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07946978) titled 'A Clinical Trial to Evaluate the Effects of a Supplement on Appetite, Gut Health, and Blood Sugar' on Nov. 12.

Brief Summary: This study evaluates the effects of the Etta Vita GLP-1 supplement on appetite, gut health, and blood sugar over a 12-week period. Thirty participants with a BMI of 25 or greater and experiencing at least two of the following issues - food cravings, poor appetite control, irregular bowel movements, bloating, or gut issues - will use the test product daily.

The trial is a single-arm, open-label study in which all participants take two capsules of the supplement each morning, no more than 15 minutes before the...